You are here

Bioiberica to participate in Natural Products Expo West 2019, with the aim of identifying strategic partnerships for the development of new ingredients

4 Mar 2019
  • Bioiberica’s Healthcare Division will also present their range of ingredients for joint health: CS b-Bioactive®, b2Cool®, Mobilee®, and Tendoactive®
  • Natural Products Expo West is the leading event worldwide in the field of natural, organic and healthy products

Bioiberica’s Healthcare Division will participate, together with their U.S. associate Berg Nutrition, at Natural Products Expo West 2019 which will be held at Anaheim, California, on 5-9 March 2019.

This event, which last year broke records by having more than 85,000 visitors and 3,521 exhibitors, is attended by the leading firms in the field of natural, organic and healthy products. This is the most important worldwide event in this field.

Bioiberica’s presence will have a double aim: on one hand, to identify new strategic partnerships with leading firms in our sector to develop new ingredients and compounds of animal origin. On the other, to present at booth #3691 of the exhibitors’ area, their range of trademark ingredients, with special focus en CS b-Bioactive®, b2Cool®, Mobilee®, and Tendoactive® - products specifically designed to improve mobility and quality of life.

Bioiberica’s Healthcare Division is a worldwide leader in pharmaceutic grade active ingredients and compounds of animal original, developed, produced and marketed by our company. Their main therapeutic area is joint healthcare.

Related News

29 May 2022

With World Digestive Health Day around, shortly followed by World Allergy Awareness Week (5-11 June), we’re exploring the increasing relevance of a relatively unknown digestive health disorder – histamine intolerance.

25 May 2022

New pre-clinical study showed that Dermial® hyaluronic acid matrix ingredient increased type I collagen production by almost half – an observation not seen with standard hyaluronic acid from fermentation or extraction origin.